New Vaccines for Next Generation COVID Virus Needed by 2022 Says BioNTech CEO
A new vaccine “tailored” to target next-generation Covid-19 will likely be needed by the middle of 2022, according to the head of BioNTech, the biotechnology company that developed the Pfizer shot. The German firm’s CEO, Uğur Şahin, told the Financial Times
Read More